Unique Nu Eyne Wearable Eye-Therapy Device Leverages STM32 Wireless Microcontroller from STMicroelectronics
September 29 2021 - 3:00AM
Unique Nu Eyne Wearable Eye-Therapy
DeviceLeverages STM32 Wireless Microcontroller
from STMicroelectronics
MCU-controlled eyewear promotes efficient tissue
regeneration and treats dry eye
Geneva, Switzerland and Seoul, Korea, September 29, 2021
– STMicroelectronics (NYSE: STM), a global semiconductor
leader serving customers across the spectrum of electronics
applications, and Nu Eyne, Korea’s innovative
medical device manufacturer, have jointly announced a Nu Eyne
wearable therapy device for eye care powered by an STM32WB55*
dual-core Bluetooth® LE (BLE) microcontroller (MCU).
Nu Eyne’s recently launched CELLENA wearable device utilizes
electric current and light emitted to the eyes and associated
nerves to relieve eye dryness and fatigue, as well as to promote
healthy retinal functions. Durable and light for everyday use, the
device supports multiple therapy sessions on a single charging
cycle and records and stores product-usage logs. A mobile
application will be released soon for greater user convenience and
interactive therapy management.
The CELLENA device relies on the dual-core architecture of the
STM32WB55 MCU for reliable wireless connectivity and real-time
processing. With its embedded security features, ST’s MCU also
delivers multiple security mechanisms, including user data
protection and encrypted firmware update over BLE. The STM32WB55’s
ultra-low-power performance also significantly extends battery
runtime of Nu Eyne’s wearable eye-therapy.
“The wireless performance of the STM32WB55 MCU inside CELLENA
exceeded our expectations and made it easier to focus on our
primary objective of delivering a product to promote tissue
regeneration and relieve dry eyes and pain,“ said Joowan Seo,
Director of Technology and Engineering, Nu Eyne. “All Nu Eyne
products are powered by MCUs from ST, which enables us to promptly
integrate new STM32 chips in our designs using the easy-to-use
STM32 development software. We have chosen ST for their consistent
and reliable high-quality products and technical support. ST
actively engages with their partners to find solutions from the
early stages of development.”
“Nu Eyne’s decision to rely on STM32 wireless MCUs for their
innovative wearable eye-therapy device is a perfect example of our
life.augmented mission to use technology to make a positive
contribution to people’s lives,” said Arnaud Julienne, Vice
President, Head of Marketing and Applications of MDG, IoT/AI
Competence Center and Digital Marketing, Asia Pacific Region,
STMicroelectronics. “This collaboration with Nu Eyne demonstrates
the tremendous potential of STM32WB MCUs for the healthcare market,
where security, together with high performance and low power, is
essential.
*STM32 is a registered and/or unregistered trademark of
STMicroelectronics International NV or its affiliates in the EU
and/or elsewhere. In particular, STM32 is registered in the US
Patent and Trademark Office.
About STMicroelectronicsAt ST, we are 46,000
creators and makers of semiconductor technologies mastering the
semiconductor supply chain with state-of-the-art manufacturing
facilities. An independent device manufacturer, we work with more
than 100,000 customers and thousands of partners to design and
build products, solutions, and ecosystems that address their
challenges and opportunities, and the need to support a more
sustainable world. Our technologies enable smarter mobility, more
efficient power and energy management, and the wide-scale
deployment of the Internet of Things and 5G technology. Further
information can be found at www.st.com.
About NUEYNENu Eyne is a medical R&D
company that focuses on utilizing electroceuticals technology to
treat various chronic diseases. For the past three years, we had
been validating the safety and efficacy of treatment concepts in
our pre-clinical animal studies, as well as from clinical trials
with university-hospitals. Our targeting indications are as
follows: dry eye disease, retinal dystrophies, migraine, facial
palsy, ADHD, and ASD. We are also pioneering in the
electroceuticals technology by focusing on novel anti-cancer
treatment protocols with a wearable device and an artificial retina
implant device for vision restoration. Further information can be
found at http://nueyne.com
For Press Information Contact:
Laney LeePress Officer, Korea STMicroelectronics Tel: +82 2 3489
0114Email: laney.lee@st.com
- T4397S -- Sep 29 2021 -- STM32WB MCU in Nu Eyne Eye
Therapy_FINAL FOR PUBLICATION
- T4397S -- Sep 29 2021 -- STM32WB MCU in Nu Eyne Eye
Therapy_IMAGE
STMicroelectronics NV (NYSE:STM)
Historical Stock Chart
From Aug 2024 to Sep 2024
STMicroelectronics NV (NYSE:STM)
Historical Stock Chart
From Sep 2023 to Sep 2024